We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · August 08, 2020

Sustained Immunotherapy and Disability Outcomes in Patients With Active Secondary Progressive MS

JAMA Neurology


Additional Info

JAMA Neurology
Association of Sustained Immunotherapy With Disability Outcomes in Patients With Active Secondary Progressive Multiple Sclerosis
JAMA Neurol 2020 Jul 27;[EPub Ahead of Print], N Lizak, CB Malpas, S Sharmin, EK Havrdova, D Horakova, G Izquierdo, S Eichau, A Lugaresi, P Duquette, M Girard, A Prat, C Larochelle, M Trojano, F Grand'Maison, P Grammond, P Sola, D Ferraro, R Hupperts, R Bergamaschi, C Boz, V Van Pesch, D Spitaleri, M Terzi, T Kalincik

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading